SDM and Adverse Outcomes
Anxiety
INTERACTIONS
At 1 wk after the consultation, observed SDM as measured with the OPTION12 was significantly related to the adverse outcomes in multivariate analysis corrected for baseline variables (Multivariate Effects of Overall Observed SDM on Adverse Outcomes at T2 (1 wk) and T3 (3 mo), When Corrected for Baseline VariablesSDM, shared decision making; STAI, State and Trait Anxiety Inventory; VAS, visual analog scale.Results are shown separately for each model (with and without interactions).Significant univariate effects of overall observed SDM on specific adverse outcomes at Indicates no significant multivariate interaction effect.Univariate Models and Effects of Overall Observed SDM on the Separate Adverse Outcomes at T2 (1 wk), when Corrected for Baseline VariablesSDM, shared decision making; STAI, State and Trait Anxiety Inventory.Significant univariate effects of overall observed SDM on specific adverse outcomes at Interactions between SDM and both preferred role (At 3 mo postconsultation (T3, sample size: Multivariate Effects of Observed SDM in the Elements of “Setting the SDM Agenda,”“Informing about the Options,” and “Exploring Patient Values and Preferences” on Adverse Outcomes, at T2 (1 wk) and T3 (3 mo), when Corrected for Baseline VariablesResults are shown separately for each model (with and without interactions).Significant univariate effects of overall observed SDM on specific adverse outcomes at 